Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter

1. Pato Pato, A.
2. Costa Arpín, E.
3. Rodríguez Regal, A.
4. Rodríguez Constenla, I.
5. Cimas Hernando, I.
6. Muñoz Pousa, I.
7. Naya Ríos, L.
8. Lorenzo González, J.R.
9. Amigo Jorrín, M.C.
10. Prieto González, J.M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.NRL.2018.02.003 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus